The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.
about
Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformansOutcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazolePoint of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITYA Single Protein S-acyl Transferase Acts through Diverse Substrates to Determine Cryptococcal Morphology, Stress Tolerance, and Pathogenic OutcomeCost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South AfricaTreatment of cryptococcosis in the setting of HIV coinfection.Opportunistic infections in HIV disease.Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report.Evidence that the human pathogenic fungus Cryptococcus neoformans var. grubii may have evolved in Africa.Risk factors for mortality from primary cryptococcosis in patients with HIV.Use of a suspension array for rapid identification of the varieties and genotypes of the Cryptococcus neoformans species complex.Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D studyPlasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole.Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.Major role for amphotericin B-flucytosine combination in severe cryptococcosis.Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.Cryptococcal meningitis: epidemiology and therapeutic options.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerCryptococcal meningitis: A neglected NTD?Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme.Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins.How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Fungal infections in transplant and oncology patients.The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda.Antifungal drug discovery through the study of invertebrate model hosts.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Effects of voriconazole on Cryptococcus neoformans.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theEpidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplantA case-control study of risk factors for HIV-negative children with cryptococcal meningitis in Shi Jiazhuang, China.Epidemiology of cryptococcal meningitis in the US: 1997-2009.An update on Cryptococcus among HIV-infected patients.Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosisCapsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrierA retrospective study of contributing factors for prognosis and survival length of cryptococcal meningoencephalitis in Southern part of China (1998-2013)Risk factors for invasive Cryptococcus neoformans diseases: a case-control study
P2860
Q24599913-2951BBA7-1618-4FDF-AD27-F125E521E306Q24678763-713A09E5-A3FE-4E1A-A884-EC18ED8EBA3FQ26746020-E974F022-56DF-4171-969C-AA1FD6CB3D66Q26783210-BA5BB4A5-71A6-4DB8-B475-C1FCCE64E36FQ27319842-B074DD0D-BB0E-4858-9B6C-BF0406E3F0FCQ28534733-858D73F4-151E-478E-9A32-EBABCE7ABFEDQ30366117-46492741-E10D-40D9-8C0C-4670B6681A1EQ30391927-D01687F9-4862-4D00-A77A-317E7B98EB27Q30987023-5F72C041-70D4-418E-B147-8FB1429C5F41Q31010702-B489E01D-DE07-4404-B3DE-655235BA9FB2Q33157255-2E3545C9-ADCE-4C87-B188-6FC4FBEDC6D7Q33221146-CB6A87F1-E9B7-425C-B98A-C40BA3621876Q33272469-30845831-0A58-4E7C-BCA2-E2CC05F7C15BQ33277939-FAA65FDB-7837-4454-9229-FB60A49C46D1Q33328474-8578AC86-ABD3-4EBC-ABD7-4DE2483D4E7CQ33358131-5D28E88C-CE30-4782-81C3-F741356E36B9Q33556039-3B61550F-0107-4977-8809-A60D86E3925AQ33633343-F030B024-884A-45AD-8D0A-FDEAF04DE1F6Q33650105-7956DB21-31BE-4430-B896-4968213C04A9Q33852819-35F3B8F4-6B3B-482D-9E50-57FDC93A4A32Q33858110-A766B30A-409A-4DDA-8912-547306FFBC9CQ33871884-0186AADE-16C6-437F-A1C6-2A915AEF0761Q33883762-61FC97B4-3D70-4D2A-B7B4-5F53EF59D318Q33894565-CF97CDD5-F12E-4E26-B1E3-0C5C165CED17Q33896940-39616A64-4DEC-4D9C-97F8-97216553F487Q33941330-217A14AB-CE29-48F5-B86B-15D68514C81AQ34002069-DCC64B64-A3CF-42D4-8A40-247EE70DBE32Q34020746-BE2FEF50-4BF0-4B1D-B86A-A5569D9E83D9Q34142180-DDBF85F5-0BDE-4D21-829E-D7CEED4E4730Q34212799-536AFBBB-734F-4349-9126-CB459343F84EQ34216198-DD611DED-AA6C-43EF-BFBB-7B4116F0B6FCQ34301547-D057085F-0422-44D6-88A1-86E694BFB9BFQ34399223-609DB8DB-65D6-4369-8F38-32375168B15DQ34522791-2FA9CEB3-A759-44C7-A6BC-8E91D8D1D635Q34606681-47F4B6C9-DABE-4BD0-9EE3-5A88F0E981B2Q34625655-7243F538-AD08-478E-9C3D-3FA9BCA893BFQ34721673-1E48A261-6CAA-4A47-967A-C2D1A9380F99Q35083658-A4396735-6C4A-4678-BA55-E53FDF07A34AQ35146191-9A129F1C-7B7D-4069-BDFD-30CE7E025FE9Q35154642-5ABF29B9-57E2-4415-9F42-A297418A4136
P2860
The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The changing epidemiology of c ...... metropolitan areas, 1992-2000.
@en
The changing epidemiology of c ...... metropolitan areas, 1992-2000.
@nl
type
label
The changing epidemiology of c ...... metropolitan areas, 1992-2000.
@en
The changing epidemiology of c ...... metropolitan areas, 1992-2000.
@nl
prefLabel
The changing epidemiology of c ...... metropolitan areas, 1992-2000.
@en
The changing epidemiology of c ...... metropolitan areas, 1992-2000.
@nl
P2093
P2860
P356
P1476
The changing epidemiology of c ...... metropolitan areas, 1992-2000.
@en
P2093
David Rimland
Edward Graviss
Gabriel Ponce de Leon
Mary E Brandt
Matthew Sattah
Maureen Phelan
Rana A Hajjeh
Richard Hamill
Sara A Mirza
Tracie Gardner
P2860
P304
P356
10.1086/368091
P407
P577
2003-02-27T00:00:00Z